15
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Interleukin-6 and Tumour Necrosis Factor Alpha Synthesized by Cholesteatoma Cells Affect Mucociliary Function in the Eustachian Tube

Pages 90-97 | Published online: 08 Jul 2009
 

Abstract

The aims of this study were to investigate the possible synthesis of IL-6 and TNF- &#102 by cholesteatoma cells in culture and the effect of IL-6 and TNF- &#102 produced by cultured cholesteatoma cells on the function of the mucociliary system in the tubotympanum. Cholesteatoma cells were collected from 10 patients, and the medium supernatants in which cholesteatoma cells or normal human epidermoid cells had been cultured for 48 h were collected. The concentrations of IL-6 and TNF- &#102 in the supernatants were measured by enzyme-linked immunosorbent assays. The effect of the culture supernatants on ciliary activity was examined using an in vitro experimental system. The supernatants were injected into the tympanic cavities of guinea pigs, and mucociliary clearance time of the Eustachian tube was determined according to our dye transport technique 24 h after the intratympanic injection. Human cholesteatoma cells produced larger amounts of IL-6 and TNF- &#102 than normal human epidermoid cells. The supernatants of cholesteatoma cells compromised ciliary activity and mucociliary clearance of the Eustachian tube in the guinea pigs. The effects of the supernatants of cholesteatoma cells on the ciliary activity and mucociliary clearance were correlated with the concentration of IL-6 and TNF- &#102 in the supernatants. In conclusion, cholesteatoma cells can produce IL-6 and TNF- &#102 , which are able to compromise the mucociliary function in the tubotympanum. IL-6 and TNF- &#102 produced in middle ear cholesteatoma might aggravate the disease by the wide range of their biological activities on the mucociliary system, the proliferation of cholesteatoma cells and the bone metabolism.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.